Organization:ImmunityBio
ImmunityBio is a life sciences company that focuses on immunotherapy.[1]
History
ImmunityBio was founded in 2014 by Dr. Patrick Soon-Shiong.[2]
In April 2020, a product developed by ImmunityBio was rumoured to be a potential SARS-CoV-2 coronavirus vaccine.[1][3]
On 1 June 2020, the product was selected for inclusion on the Operation Warp Speed subsidy list, in order to fund trials involving non-human primates.[4] The company "hope to receive approval from the Food and Drug Administration to begin an initial safety trial in humans in June 2020."[4]
Covid-19 vaccine
The ImmunityBio COVID-19 vaccine, codenamed hAd5, is a COVID-19 vaccine developed by the United States-based ImmunityBio.[5][6]
The BioVac Institute, a state-backed South Africa vaccine company, plans to use a deal it won to manufacture coronavirus vaccines. The contract with United States based ImmunityBio Inc is currently conducting phase 1 vaccine trials in South Africa [7]
ImmunityBio and BioVac plan to distribute the vaccines throughout South Africa and Africa.[8][9]
Phase I/II
ImmunityBio Inc is currently conducting phase 1 vaccine trials in The United States and South Africa .[10]
References
- ↑ 1.0 1.1 "NantKwest and ImmunityBio Announce Therapeutics and Vaccines for Combatting COVID-19; Clinical Trials Anticipated to Begin This Quarter". BioSpace.com. 14 April 2020. https://www.biospace.com/article/releases/nantkwest-and-immunitybio-announce-therapeutics-and-vaccines-for-combatting-covid-19-clinical-trials-anticipated-to-begin-this-quarter/.
- ↑ "Oral COVID-19 vaccine being tested in Los Angeles-area research center" (in en-US). https://www.cbsnews.com/news/covid-19-vaccine-oral-testing-los-angeles/.
- ↑ Cross, Ryan (12 May 2020). "Adenoviral vectors are the new COVID-19 vaccine front-runners. Can they overcome their checkered past?". Chemical & Engineering News 98 (19). https://cen.acs.org/pharmaceuticals/vaccines/Adenoviral-vectors-new-COVID-19/98/i19.
- ↑ 4.0 4.1 Cohen, Jon (1 June 2020). "Operation Warp Speed selects billionaire scientist’s COVID-19 vaccine for monkey tests". Science (magazine). American Association for the Advancement of Science. https://www.sciencemag.org/news/2020/06/operation-warp-speed-selects-billionaire-scientist-s-covid-19-vaccine-monkey-tests.
- ↑ "SA’s Biovac to team up with US based ImmunityBio in making its vaccine". https://www.businessinsider.co.za/sas-biovac-to-team-up-with-us-based-immunitybio-in-making-its-vaccine-2021-3.
- ↑ "ImmunityBio Inc: hAd5-Covid-19 – COVID19 Vaccine Tracker". https://covid19.trackvaccines.org/vaccines/49/.
- ↑ "Covid-19 to Serve as Platform for South African Vaccine Industry" (in en). Bloomberg.com. 2021-03-19. https://www.bloomberg.com/news/articles/2021-03-19/immunitybio-to-have-covid-19-vaccine-made-in-south-africa.
- ↑ Fisher, Shamiela. "Nzimande excited about vaccine partnership between Biovac & ImmunityBio" (in en). https://ewn.co.za/2021/03/18/nzimande-announces-manufacturing-partnership-between-sa-s-biovac-and-us-firm-immunitybio.
- ↑ Sguazzin, Antony. "SA's BioVac to use deal with US-based ImmunityBio to boost local vaccine creation, CEO says" (in en-US). https://www.news24.com/fin24/companies/health/sas-biovac-to-use-deal-with-us-based-immunitybio-to-boost-local-vaccine-creation-ceo-says-20210320.
- ↑ "Covid-19 to Serve as Platform for South African Vaccine Industry" (in en). Bloomberg.com. 2021-03-19. https://www.bloomberg.com/news/articles/2021-03-19/immunitybio-to-have-covid-19-vaccine-made-in-south-africa.
 |
